Back to search

Article

The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone

2022-05-07

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Reductionist two-dimensional (2D) in vitro assays have long been the standard for studying the metastatic abilities of cancer cells. However, tri-dimensional (3D) organotypic models provide a more complex environment, closer to that seen in patients, and thereby provide a more accurate representation of their true capabilities. Our laboratory has previously shown that the an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ad73eb2-149c-5560-a09b-f5758dfcb650
DOI
10.1101/2022.05.07.491021
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristoneDOI 10.1101/2022.05.07.491021
Select a neighboring publication to make it the new centre.